Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 


NF-κB inhibitor
ALX-350-121-C100 100 µg 534.00 USD
Do you need bulk/larger quantities?
Immunosuppressant. Potent inhibitor of NF-κB activation in T cells, with an almost complete inhibition at 200nM. Suppresses cytokine production (IFN-γ, TNF-α, IL-2 and IL-4) and inhibits NF-AT in peripheral blood T cells at concentrations that do not impair NF-κB and AP-1 activities. In contrast to the immunosuppressant cyclosporin A (Prod. No. BML-A195), rocaglamide does not inhibit calcineurin phosphatase activity. Induces apoptosis.

Product Details

Alternative Name:Rocaglamide A
Purity:≥98% (HPLC)
Appearance:White to off-white sticky solid.
Solubility:Soluble in DMSO, 100% ethanol or methanol.
Shipping:Ambient Temperature
Long Term Storage:-20°C
Handling:Protect from light.
Regulatory Status:RUO - Research Use Only
Please mouse over

Product Literature References

The prohibitin-binding compound fluorizoline inhibits mitophagy in cancer cells: S. Núñez-Vázquez, et al.; Oncogenesis 10, 64 (2021), Abstract;
New acyclic bis phenylpropanoid and neolignans, from Myristica fragrans Houtt., exhibiting PARP-1 and NF-κB inhibitory effects: U.M. Acuna, et al.; Food. Chem. 202, 269 (2016), Application(s): Positive control, Abstract;
Rocaglamide and a XIAP inhibitor cooperatively sensitize TRAIL-mediated apoptosis in Hodgkin's lymphomas: M. Giaisi, et al.; Int. J. Cancer. 131, 1003 (2012), Abstract;
Rocaglamide sensitizes leukemic T cells to activation-induced cell death by differential regulation of CD95L and c-FLIP expression.: J.Y. Zhu, et al.; Cell Death Differ. 16, 1289 (2009), Abstract;
The traditional Chinese herbal compound rocaglamide preferentially induces apoptosis in leukemia cells by modulation of mitogen-activated protein kinase activities: J.Y. Zhu, et al.; Int. J. Cancer 121, 1839 (2007), Abstract;
Potent cytotoxic rocaglamide derivatives from the fruits of Amoora cucullata: P. Chumkaew, et al.; Chem. Pharm. Bull. 54, 1344 (2006), Abstract;
Potential of cyclopenta[b]benzofurans from Aglaia species in cancer chemotherapy: S. Kim, et al.; Anticancer Agents Med. Chem. 6, 319 (2006), Abstract;
Rocaglamide derivatives are immunosuppressive phytochemicals that target NF-AT activity in T cells: P. Proksch, et al.; J. Immunol. 174, 7075 (2005), Abstract; Full Text
Rocaglamide derivatives are potent inhibitors of NF-kappa B activation in T-cells: B. Baumann, et al.; J. Biol. Chem. 277, 44791 (2002), Abstract; Full Text
New insecticidal rocaglamide derivatives and related compounds from Aglaia oligophylla: M. Dreyer, et al.; J. Nat. Prod. 64, 415 (2001), Abstract;
Rocaglamides, glycosides, and putrescine bisamides from Aglaia dasyclada: Chaidir, et al.; J. Nat. Prod. 64, 1216 (2001), Abstract;
Cyclopenta[b]benzofurans from Aglaia species with pronounced antifungal activity against rice blast fungus (Pyricularia grisea): D. Engelmeier, et al.; J. Agric. Food Chem. 48, 1400 (2000), Abstract;
Insecticidal rocaglamide derivatives from Aglaia spectabilis (Meliaceae): C. Schneider, et al.; Phytochemistry 54, 731 (2000), Abstract;
X-ray crystal structure of rocaglamide, a novel antileukemic 1H-cyclopenta-(b)-benzofuran from Aglaia elliptofolia: M.L. King, et al.; J. C. S. Chem. Commun. 20, 1150 (1982),

Related Products

Cyclosporin A 

59865-13-3, Isolated from Fusarium solani, ≥98% (Assay) | Print as PDF
BML-A195-0100 100 mg 75.00 USD
BML-A195-0500 500 mg 309.00 USD
Do you need bulk/larger quantities?

Rocaglamide I 

NF-κB inhibitor
189322-68-7, Isolated from Aglaia sp., ≥97% (HPLC) | Print as PDF
ALX-350-142-C050 50 µg 128.00 USD
Do you need bulk/larger quantities?